The role of CXCL12 and CCL7 chemokines in immune regulation, embryonic development, and tissue regeneration

Cytokine

Volumn 69, Issue 2, 2014, Pages 277-283

  Cheng, Julie W ^a   Sadeghi, Zhina ^a   Levine, Alan D ^b   Penn, Marc S ^c   von Recum, Horst A ^d   Caplan, Arnold I ^b   Hijaz, Adonis ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SUMMA HEALTH SYSTEM   (United States)

^d Case Western Reserve University   (United States)

Author keywords

Chemokine ligand 12; Chemokine ligand 7; Chemokines

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; BONE REMODELING; BRAIN INJURY; CELL MIGRATION; CLINICAL TRIAL (TOPIC); ELECTROSTIMULATION; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; FRACTURE; HEART FAILURE; HEART INFARCTION; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; INJURY; ISCHEMIC CARDIOMYOPATHY; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; PELVIC FLOOR DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE DRUG DOSE; STEM CELL; TISSUE REGENERATION; WOUND HEALING; ANIMAL; IMMUNITY; METABOLISM; PATHOLOGY; REGENERATION;

ANIMALS; CHEMOKINE CCL7; CHEMOKINE CXCL12; EMBRYONIC DEVELOPMENT; HUMANS; IMMUNITY; REGENERATION; WOUNDS AND INJURIES;

EID: 84928813112     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2014.06.007     Document Type: Review

References (102)

1. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
2. Caplan A.I., Correa D. The MSC: an injury drugstore. Cell Stem Cell 2011, 9:11-15.
3. Roobrouck V.D., Clavel C., Jacobs S.A., et al. Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions. Stem Cells 2011, 29:871-882.
4. Kogler G., Sensken S., Airey J.A., et al. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med 2004, 200:123-135.
5. Chapel A., Bertho J.M., Bensidhoum M., et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003, 5:1028-1038.
6. Orlic D., Kajstura J., Chimenti S., et al. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001, 98:10344-10349.
7. Corcos J., Loutochin O., Campeau L., et al. Bone marrow mesenchymal stromal cell therapy for external urethral sphincter restoration in a rat model of stress urinary incontinence. Neurourol Urodyn 2011, 30:447-455.
8. Fu Q., Song X.F., Liao G.L., et al. Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence. Urology 2010, 75:718-723.
9. Wu G., Song Y., Zheng X., Jiang Z. Adipose-derived stromal cell transplantation for treatment of stress urinary incontinence. Tissue Cell 2011, 43:246-253.
10. Mahmood A., Lu D., Chopp M. Intravenous administration of marrow stromal cells (MSCs) increases the expression of growth factors in rat brain after traumatic brain injury. J Neurotrauma 2004, 21:33-39.
11. Lu D., Mahmood A., Wang L., et al. Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome. Neuroreport 2001, 12:559-563.
12. Kumagai K., Vasanji A., Drazba J.A., et al. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J Orthop Res 2008, 26:165-175.
13. Bai L., Lennon D.P., Eaton V., et al. Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. Glia 2009, 57:1192-1203.
14. Bonfield T.L., Koloze M., Lennon D.P., et al. Human mesenchymal stem cells suppress chronic airway inflammation in the murine ovalbumin asthma model. Am J Physiol Lung Cell Mol Physiol 2010, 299:L760-L770.
15. Barbash I.M., Chouraqui P., Baron J., et al. Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 2003, 108:863-868.
16. Freyman T., Polin G., Osman H., et al. A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 2006, 27:1114-1122.
17. Devine S.M., Cobbs C., Jennings M., et al. Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into nonhuman primates. Blood 2003, 101:2999-3001.
18. Ponte A.L., Marais E., Gallay N., et al. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
19. Shirozu M., Nakano T., Inazawa J., et al. Structure and chromosomal localization of the human stromal cell-derived factor 1 (SDF1) gene. Genomics 1995, 28:495-500.
20. Aiuti A., Webb I.J., Bleul C., et al. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J Exp Med 1997, 185:111-120.
21. Tanabe S., Heesen M., Yoshizawa I., et al. Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 1997, 159:905-911.
22. Wynn R.F., Hart C.A., Corradi-Perini C., et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004, 104:2643-2645.
23. Feng Y., Broder C.C., Kennedy P.E., Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996, 272:872-877.
24. von Recum H.A., Pokorski J.K. Peptide and protein-based inhibitors of HIV-1 co-receptors. Exp Biol Med 2013, 238:442-449.
25. Kim C.H., Broxmeyer H.E. In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment. Blood 1998, 91:100-110.
26. Hattori K., Heissig B., Tashiro K., et al. Plasma elevation of stromal cell-derived factor-1 induces mobilization of mature and immature hematopoietic progenitor and stem cells. Blood 2001, 97:3354-3360.
27. Mohle R., Bautz F., Rafii S., et al. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998, 91:4523-4530.
28. Kortesidis A., Zannettino A., Isenmann S., et al. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801.
29. Cashman J., Clark-Lewis I., Eaves A., Eaves C. Stromal-derived factor 1 inhibits the cycling of very primitive human hematopoietic cells in vitro and in NOD/SCID mice. Blood 2002, 99:792-799.
30. Bleul C.C., Fuhlbrigge R.C., Casasnovas J.M., et al. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109.
31. Suzuki Y., Rahman M., Mitsuya H. Diverse transcriptional response of CD4(+) T cells to stromal cell-derived factor (SDF)-1: cell survival promotion and priming effects of SDF-1 on CD4(+) T cells. J Immunol 2001, 167:3064-3073.
32. Van Damme J., Proost P., Lenaerts J.P., Opdenakker G. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992, 176:59-65.
33. Opdenakker G., Fiten P., Nys G., et al. The human MCP-3 gene (SCYA7): cloning, sequence analysis, and assignment to the C-C chemokine gene cluster on chromosome 17q11.2-q12. Genomics 1994, 21:403-408.
34. Polentarutti N., Introna M., Sozzani S., et al. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw 1997, 8:271-274.
35. Kim K.S., Rajarathnam K., Clark-Lewis I., Sykes B.D. Structural characterization of a monomeric chemokine: monocyte chemoattractant protein-3. FEBS Lett 1996, 395:277-282.
36. Ben-Baruch A., Xu L., Young P.R., et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors. C-C CKR1, a receptor for macrophage inflammatory protein-1 alpha/Rantes, is also a functional receptor for MCP3. J Biol Chem 1995, 270:22123-22128.
37. Tsou C.L., Peters W., Si Y., et al. Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites. J Clin Invest 2007, 117:902-909.
38. Schenk S., Mal N., Finan A., et al. Monocyte chemotactic protein-3 is a myocardial mesenchymal stem cell homing factor. Stem Cells 2007, 25:245-251.
39. Wood H.M., Kuang M., Woo L., et al. Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats. J. Urol. 2008, 180:753-759.
40. Bonaros N., Sondermeijer H., Schuster M., et al. CCR3- and CXCR4-mediated interactions regulate migration of CD34+ human bone marrow progenitors to ischemic myocardium and subsequent tissue repair. J Thorac Cardiovasc Surg 2008, 136:1044-1053.
41. Bousquenaud M., Schwartz C., Leonard F., et al. Monocyte chemotactic protein 3 is a homing factor for circulating angiogenic cells. Cardiovasc Res 2012, 94:519-525.
42. Xu L.L., McVicar D.W., Ben-Baruch A., et al. Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol 1995, 25:2612-2617.
43. Dezerega A., Osorio C., Mardones J., et al. Monocyte chemotactic protein-3: possible involvement in apical periodontitis chemotaxis. Int Endod J 2010, 43:902-908.
44. Santiago J., Hernandez-Cruz J.L., Manjarrez-Zavala M.E., et al. Role of monocyte chemotactic protein-3 and -4 in children with virus exacerbation of asthma. Eur Respir J 2008, 32:1243-1249.
45. Loetscher P., Seitz M., Clark-Lewis I., et al. Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 1994, 8:1055-1060.
46. Proost P., Wuyts A., Van Damme J. Human monocyte chemotactic proteins-2 and -3: structural and functional comparison with MCP-1. J Leukoc Biol 1996, 59:67-74.
47. Taub D.D., Proost P., Murphy W.J., et al. Monocyte chemotactic protein-1 (MCP-1), -2, and -3 are chemotactic for human T lymphocytes. J Clin Invest 1995, 95:1370-1376.
48. Alam R., Forsythe P., Stafford S., et al. Monocyte chemotactic protein-2, monocyte chemotactic protein-3, and fibroblast-induced cytokine. Three new chemokines induce chemotaxis and activation of basophils. J Immunol 1994, 153:3155-3159.
49. Allavena P., Bianchi G., Zhou D., et al. Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 1994, 24:3233-3236.
50. Sozzani S., Luini W., Borsatti A., et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 1997, 159:1993-2000.
51. Noso N., Proost P., Van Damme J., Schroder J.M. Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994, 200:1470-1476.
52. Fioretti F., Fradelizi D., Stoppacciaro A., et al. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor. J Immunol 1998, 161:342-346.
53. Wetzel K., Menten P., Opdenakker G., et al. Transduction of human MCP-3 by a parvoviral vector induces leukocyte infiltration and reduces growth of human cervical carcinoma cell xenografts. J Gene Med 2001, 3:326-337.
54. Sun Y.X., Wang J., Shelburne C.E., et al. Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo. J Cell Biochem 2003, 89:462-473.
55. Cho Y.B., Lee W.Y., Choi S.J., et al. CC chemokine ligand 7 expression in liver metastasis of colorectal cancer. Oncol Rep 2012, 28:689-694.
56. Muller A., Homey B., Soto H., et al. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
57. Hwang T.L., Lee L.Y., Wang C.C., et al. CCL7 and CCL21 overexpression in gastric cancer is associated with lymph node metastasis and poor prognosis. World J Gastroenterol 2012, 18:1249-1256.
58. Doitsidou M., Reichman-Fried M., Stebler J., et al. Guidance of primordial germ cell migration by the chemokine SDF-1. Cell 2002, 111:647-659.
59. Tachibana K., Hirota S., Iizasa H., et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998, 393:591-594.
60. Nagasawa T., Hirota S., Tachibana K., et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996, 382:635-638.
61. Ma Q., Jones D., Borghesani P.R., et al. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci USA 1998, 95:9448-9453.
62. Zou Y.R., Kottmann A.H., Kuroda M., et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998, 393:595-599.
63. Brustle O., Spiro A.C., Karram K., et al. In vitro-generated neural precursors participate in mammalian brain development. Proc Natl Acad Sci USA 1997, 94:14809-14814.
64. Stumm R.K., Zhou C., Ara T., et al. CXCR4 regulates interneuron migration in the developing neocortex. J Neurosci 2003, 23:5123-5130.
65. Ni H.T., Hu S., Sheng W.S., et al. High-level expression of functional chemokine receptor CXCR4 on human neural precursor cells. Brain Res Dev 2004, 152:159-169.
66. Tham T.N., Lazarini F., Franceschini I.A., et al. Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur J Neurosci 2001, 13:845-856.
67. Lu M., Grove E.A., Miller R.J. Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor. Proc Natl Acad Sci USA 2002, 99:7090-7095.
68. Klein R.S., Rubin J.B., Gibson H.D., et al. SDF-1 alpha induces chemotaxis and enhances sonic hedgehog-induced proliferation of cerebellar granule cells. Development 2001, 128:1971-1981.
69. Li F., Huang Q., Chen J., et al. Apoptotic cells activate the "phoenix rising" pathway to promote wound healing and tissue regeneration. Sci Signal 2010, 3:ra13.
70. Abbott J.D., Huang Y., Liu D., et al. Stromal cell-derived factor-1alpha plays a critical role in stem cell recruitment to the heart after myocardial infarction but is not sufficient to induce homing in the absence of injury. Circulation 2004, 110:3300-3305.
71. Unzek S., Zhang M., Mal N., et al. SDF-1 recruits cardiac stem cell-like cells that depolarize in vivo. Cell Transplant 2007, 16:879-886.
72. Damas J.K., Waehre T., Yndestad A., et al. Stromal cell-derived factor-1alpha in unstable angina: potential antiinflammatory and matrix-stabilizing effects. Circulation 2002, 106:36-42.
73. Askari A.T., Unzek S., Popovic Z.B., et al. Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 2003, 362:697-703.
74. Vricella G.J., Tao M., Altuntas C.Z., et al. Expression of monocyte chemotactic protein 3 following simulated birth trauma in a murine model of obesity. Urology 2010, 76. 1517.e12-17.
75. Woo L.L., Hijaz A., Kuang M., et al. Over expression of stem cell homing cytokines in urogenital organs following vaginal distention. J Urol 2007, 177:1568-1572.
76. Salcedo L., Sopko N., Jiang H.H., et al. Chemokine upregulation in response to anal sphincter and pudendal nerve injury: potential signals for stem cell homing. Int J Colorectal Dis 2011, 26:1577-1581.
77. Ji J.F., He B.P., Dheen S.T., Tay S.S. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 2004, 22:415-427.
78. Hill W.D., Hess D.C., Martin-Studdard A., et al. SDF-1 (CXCL12) is upregulated in the ischemic penumbra following stroke: association with bone marrow cell homing to injury. J Neuropathol Exp Neurol 2004, 63:84-96.
79. Imitola J., Raddassi K., Park K.I., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 2004, 101:18117-18122.
80. Miller J.T., Bartley J.H., Wimborne H.J., et al. The neuroblast and angioblast chemotaxic factor SDF-1 (CXCL12) expression is briefly up regulated by reactive astrocytes in brain following neonatal hypoxic-ischemic injury. BMC Neurosci 2005, 6:63.
81. Otsuru S., Tamai K., Yamazaki T., et al. Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells 2008, 26:223-234.
82. Kitaori T., Ito H., Schwarz E.M., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 2009, 60:813-823.
83. Schober A., Knarren S., Lietz M., et al. Crucial role of stromal cell-derived factor-1alpha in neointima formation after vascular injury in apolipoprotein E-deficient mice. Circulation 2003, 108:2491-2497.
84. Kollet O., Shivtiel S., Chen Y.Q., et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003, 112:160-169.
85. Togel F., Isaac J., Hu Z., et al. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005, 67:1772-1784.
86. Penn M.S., Zhang M., Deglurkar I., Topol E.J. Role of stem cell homing in myocardial regeneration. Int J Cardiol 2004, 95(Suppl. 1):S23-S25.
87. Zhang M., Mal N., Kiedrowski M., et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 2007, 21:3197-3207.
88. Penn M.S., Mendelsohn F.O., Schaer G.L., et al. An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res 2013, 112:816-825.
89. Kopen G.C., Prockop D.J., Phinney D.G. Marrow stromal cells migrate throughout forebrain and cerebellum, and they differentiate into astrocytes after injection into neonatal mouse brains. Proc Natl Acad Sci USA 1999, 96:10711-10716.
90. Shinohara K., Greenfield S., Pan H., et al. Stromal cell-derived factor-1 and monocyte chemotactic protein-3 improve recruitment of osteogenic cells into sites of musculoskeletal repair. J Orthop Res 2011, 29:1064-1069.
91. Jung Y., Wang J., Schneider A., et al. Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing. Bone 2006, 38:497-508.
92. Salvucci O., Yao L., Villalba S., et al. Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002, 99:2703-2711.
93. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 2003, 107:1322-1328.
94. Hiasa K., Ishibashi M., Ohtani K., et al. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization. Circulation 2004, 109:2454-2461.
95. Petit I., Szyper-Kravitz M., Nagler A., et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002, 3:687-694.
96. McQuibban G.A., Butler G.S., Gong J.H., et al. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J Biol Chem 2001, 276:43503-43508.
97. McQuibban G.A., Gong J.H., Tam E.M., et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000, 289:1202-1206.
98. Fedyk E.R., Jones D., Critchley H.O.D., et al. Expression of stromal-derived factor-1 is decreased by IL-1 and TNF and in dermal wound healing. J Immunol 2001, 166:5749-5755.
99. Ceradini D.J., Kulkarni A.R., Callaghan M.J., et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 2004, 10:858-864.
100. Liu H., Xue W., Ge G., et al. Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs. Biochem Biophys Res Commun 2010, 401:509-515.
101. Gardner S.E., Frantz R.A., Schmidt F.L. Effect of electrical stimulation on chronic wound healing: a meta-analysis. Wound Repair Regen 1999, 7:495-503.
102. Salcedo L., Lian L., Jiang H.H., et al. Low current electrical stimulation upregulates cytokine expression in the anal sphincter. Int J Colorectal Dis 2012, 27:221-225.